Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement

By SquaredTown on October 25, 2025

The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch HANGZHOU, China, Oct. 25, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as the "Company") today announced the successful...

Read More